SHE HAS BEEN CONVICTED, SENTENCED AND LOCKED UP — AND SHE STILL SAYS SHE DIDN'T DO IT. From a federal prison in Texas, Elizabeth Holmes told People that being there has been “hell and torture,” that she never lied to anyone, and that she still believes the technology would have changed the world. The record says something else, and it says it in counts.
What she said, in her words
The interview ran in People and was reported on air by TODAY. In it Holmes describes the sentence as “hell and torture,” says there has not been a day she has stopped working on her research and inventions from inside, and repeats her commitment to affordable health care.
The most important line is not the one about prison. It is the one about guilt: she does not believe she defrauded anyone or lied to anyone. She believes in the technology, and believes that with more time she would have changed the world.
That is not a legal argument. It is a belief, stated plainly, by a person a jury found had made false statements to investors — and the two things can be true at once, which is the whole story.
The numbers the verdict rests on
Theranos was founded in 2003, when Holmes was 19. By 2014 the company was valued at about $9 billion, and she was being described as the youngest self-made female billionaire in America. The pitch was a machine that could run hundreds of tests on a fingerstick of blood.
In October 2015 the Wall Street Journal published reporting that the technology did not work as described. In March 2018 the SEC charged Holmes, the company and its president with raising money on false claims; Holmes settled, paying a $500,000 penalty and accepting a 10-year bar from serving as an officer or director of a public company, without admitting or denying the findings.
The criminal case went further. In January 2022 a federal jury convicted her on four counts — three of wire fraud against investors and one of conspiracy — and acquitted her on four counts relating to patients. In November 2022 the judge sentenced her to 135 months: eleven years and three months. She reported to prison in May 2023.
Why “I believed it” was never going to be the defence
Wire fraud is about what you told people, knowing it was not true, to get their money. A defendant's sincere belief in the mission does not erase a sentence like “our device does this, today, on this many tests.” The jury did not have to decide whether Holmes is a true believer. It had to decide whether the statements were false when she made them and whether she knew.
This is why the case is a business story before it is a crime story. The product of Theranos was not only a blood test — it was a valuation. Investors were not buying a lab; they were buying the story that made the number true, and the number was $9 billion.
The voice was part of the product
The same coverage noted that the baritone she used as chief executive is gone. On the record now she speaks in what the reporting calls a normal voice. That detail is not gossip; it is the mechanism of the whole story in miniature: a performance, maintained for years, that stopped being necessary once there was no one left to raise money from.
Where it stands
Holmes is serving her sentence in a federal prison in Texas and is appealing. Reporting on the interview says the sentence has been reduced to roughly nine years for good behaviour, with release expected around 2032.
Her former partner and Theranos president, Ramesh “Sunny” Balwani, was convicted separately in July 2022 on 12 counts of fraud and conspiracy and sentenced in December 2022 to 155 months — nearly thirteen years. He surrendered in March 2023.
The split verdict is the story
Read the two halves of that verdict together and the case gets sharper. Guilty of defrauding the people who put money in. Not guilty on the counts that involved patients — the people whose tests came back wrong.
That is not a technicality; it is the jury drawing a line between money and medicine. The investors were told a number and a capability; the patients were told a result. The jury convicted on the first and acquitted on the second, which tells you exactly what the evidence supported and what it did not.
What the machine was supposed to do
The pitch was a box called the Edison: a fingerstick of blood, no venous draw, hundreds of tests run fast and cheap inside a machine the size of a printer. Walgreens put it in stores. The company raised hundreds of millions on that picture, and the valuation followed the picture rather than the lab.
The reporting that broke it in October 2015 found the device ran a small fraction of the tests it claimed, and that many samples were being run on commercially available machines instead. That gap — between the demonstration and the instrument — is what the investors were never told, and it is what the four counts are about.
Why the board did not save her
Theranos assembled a board of former cabinet secretaries and statesmen, and that board is usually described as evidence that the fraud was impossible to see. It is better read the other way: none of them ran a lab. Prestige on a board is not diligence, and it is not a defence — for the company or for the founder.
The $125 million that sold for a dollar
The investor list is where the story stops being about a startup and starts being about who gets access. According to the Wall Street Journal’s reporting in March 2017, Rupert Murdoch — whose company owned that newspaper — had put $125 million into Theranos and sold the entire stake for $1.
He was not the largest loser. WSJ reported the Walton family heirs had invested about $150 million, the biggest single position, and that Betsy DeVos had put in about $100 million. These were not venture funds doing diligence across a portfolio. They were individuals writing enormous cheques into a company whose product they could not test themselves.
BioSpace carried the Murdoch sale on 27 March 2017 in a piece by Alex Keown, which is where most readers met the number. The detail that makes it a page rather than a footnote: the owner of the paper that exposed the fraud lost $124,999,999 on the same company, and the exposure did not save him a dollar of it.
She asked the owner of the paper to kill the story
Before the Journal published, Holmes went over the reporter’s head — to the man who owned the newspaper. In testimony in November 2021 she admitted appealing directly to Rupert Murdoch to stop the Wall Street Journal’s reporting on Theranos. He declined, and the story ran in October 2015.
That is the same Murdoch who had $125 million in the company and later sold the stake for $1. He was the largest kind of mark and the owner of the press at the same time, and when the founder asked him to choose, he let the story run. Whatever else that is, it is not the behaviour of a man protecting an investment.
The $350 million that belonged to somebody else
The popular version of this story says Walgreens put $350 million into refitting 800 stores for Theranos. The record does not support that number. Walgreens invested more than $140 million in Theranos itself, including a $40 million convertible loan.
The $350 million figure belongs to Safeway — a separate, larger planned rollout that collapsed, with Safeway severing ties as the relationship fell apart. Two pharmacy giants, two different deals, one number that gets attached to the wrong company in most retellings.
The cheque, and the letter that came later
The first real money came from someone who knew her. Tim Draper — an early investor in Skype and Hotmail — wrote Holmes a $1 million cheque when she was 19 and had just left Stanford. When she was convicted, he still said publicly that he believed in what she was trying to do.
He put it in writing. Draper was among the people who filed 130 letters seeking leniency before her sentencing in November 2022. Whatever that says about loyalty in Silicon Valley, it says something else about this case: the people closest to the money never stopped believing the story, and some of them still don’t.
The board was warned in 2008
Long before the Journal, two senior insiders went to the board with evidence that Holmes had overstated revenue projections to directors. The board considered replacing her with an experienced executive. It did not happen — she kept the job.
That is the fact the documentaries tend to leave out, because it makes a better story if nobody knew. Somebody knew in 2008. The people with fiduciary duty were told, considered the alternative, and chose the founder.
SPLASH'S READ
Here is what makes this page worth writing years after the verdict: she is not pretending she was misunderstood. She is telling a magazine that she never lied, from a prison cell, with the conviction standing.
That is the difference between being wrong and being a fraud, and it is the only question in the case. Everybody who ever built something believed in it. The belief is free. The sentence came from the statements.
And the tell is in the voice. The baritone was a costume she put on to make people hand over money. It came off the day she stopped needing it.
Sources & claims: Sources & claims, claim by claim. Prison interview and quotes:
People magazine interview with Elizabeth Holmes, reported on air by TODAY (NBC), including “hell and torture,” the statement that she does not believe she defrauded or lied to anyone, the ongoing research work, the voice description, the reduced sentence and the projected 2032 release. Criminal case: U.S. v. Elizabeth Holmes, No. 18-cr-00258 EJD (N.D. Cal.) — verdict 3 Jan 2022 (three counts of wire fraud, one count of conspiracy; acquitted on four patient counts); sentencing 18 Nov 2022, 135 months, Judge Edward Davila. Balwani: No. 18-cr-00258-2 EJD, convicted July 2022 on 12 counts, sentenced 7 Dec 2022 to 155 months. Investor losses:
Wall Street Journal reporting, March 2017 (Murdoch $125M stake sold for $1; Walton heirs ~$150M; DeVos ~$100M), with the sale also reported by Business Insider, 23 Mar 2017, and BioSpace (Alex Keown), 27 Mar 2017. SEC: Securities and Exchange Commission, 14 Mar 2018 — $500,000 penalty, 10-year officer/director bar, neither admitted nor denied. Company history and valuation: contemporaneous reporting and the
Wall Street Journal reporting of October 2015. Draper: $1M cheque reported at the time and confirmed in the 2022 sentencing-coverage of the 130 leniency letters. 2008 board warning: Stanford GSB case study of the Theranos collapse (two insiders, overstated revenue projections, board considered replacing her). Murdoch appeal: Holmes’ own testimony, 30 Nov–1 Dec 2021 (reported by WSJ and Reuters). Partner numbers: Walgreens >$140M including a $40M convertible loan; Safeway’s $350M deal collapsed (Fierce Biotech and contemporaneous reporting). Video sources: Coffee and Cults,
Everything You Don't Know About Elizabeth Holmes; It's Blanko,
How Elizabeth Holmes (almost) got away with it (which carries the TEDMED 2014 clip); TODAY,
Elizabeth Holmes talks 'hell and torture' of prison. Her denial is reported as her statement, not adopted by this page; the conviction and sentence are matters of record.